Scientific Publications & Original Research
Exploring over two decades of peer-reviewed literature, international consensus recommendations, digital health breakthroughs, and clinical trials in diabetology.
Articles
Categories
Research
SWEET / RSSDI
The Severity of Breakthrough Infections Post-COVID-19 Vaccination in Healthcare and Public Sector in South India.
Kesavadev, Jothydev; Manojan, K. K.1; Benny, P. V.2; Raj, Sumesh1; Shankar, Arun; Krishnan, Gopika; Basanth, Anjana; Jothydev, Sunitha. International Journal of Diabetes and Technology 1(1):p 46-50, Jan–Mar 2022. | DOI: 10.4103/ijdt.ijdt_6_22
Diabetic ketoacidosis in COVID new-onset patients.
Saboo, B., Mehta, J., Ghosh, S., Kesavadev, J. Critical Care Update 2022, 4, March 2022, p. 761-766
COVID-19 associated mucormycosis: A Descriptive Multisite Study from India.
Gupta R, Kesavadev J, Krishnan G, Agarwal S, Saboo B, Shah M, Mittal A, Durani S, Luthra A, Singhal A, Rasheed M. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. Oct 2021:102322.
A new interventional home care model for COVID management: Virtual Covid IP.
Kesavadev J, Basanth A, Krishnan G, Vitale R, Parameswaran H, Shijin S, Sreelakshmi R, Raj S, Ashik A, Shankar A, Badarudeen S. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021 Jul 23:102228.
Management Strategies for Dealing With Surges of the COVID-19 Pandemic.
Raveendran A, Kesavadev J, Hari P, Krishnan G. Cureus 13(6). June 2021.
Steroid use during COVID-19 infection and hyperglycemia–What a physician should know.
Sosale A, Sosale B, Kesavadev J, Chawla M, Reddy S, Saboo B, Misra A. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. Jun 2021.
Impact of Webinars and Telemedicine during COVID-19 Lockdown in Transforming Outcomes in 848 T2D Patients in India.
Kesavadev J, Shankar A, Krishnan G, Basanth A, Jothydev K, Chandran B, S. S, Jothydev S. ADA, 81ST Scientific Sessions, Virtual, June 25-29, 2021. 468-P
Virtual Covid IP Care In Diabetes: Concept to Reality.
Kesavadev. J, Shankar. A, Unes. Y, Shijin. S, Manoj. A, Rajalakshmi S, Jose. R, Krishnan G, Jothydev. S. Advanced Technologies & Treatments for Diabetes, 14th International Conference, Virtual, June 2021. Oral Presentation
Rediscovering The Power Of Telemedicine (DTMS®) In The Covid Era.
Kesavadev J, Saboo B, Shankar A, Krishnan G, Ashok A, Ajith J, Manoj A, S. S, Basanth A, Jyogesh S, Jothydev S. Advanced Technologies & Treatments for Diabetes, 14th International Conference, Virtual, June 2021.
Using Telemedicine and remote monitoring for diabetes during COVID-19: The Indian experience.
Advanced Technologies & Treatments for Diabetes, 14th International Conference, Virtual, June 2021. Invited Lecture- Dr.Jothydev Kesavadev.
Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel.
Chawla M, Jain SM, Kesavadev J, Makkar BM, Viswanathan V, Tiwaskar M, Sosale AR, Negalur V, Modi KD, Gupta M, Kumar S, Ramakrishnan S, Deka N, Roy N. Diabetes Ther. 2020 Dec 12:1–10. doi: 10.1007/s13300-020-00979-8.
Management of children and adolescents having type 1 diabetes during COVID-19 pandemic in India: challenges and solutions.
Jethwani P, Saboo B, Jethwani L, Kesavadev J, Kalra S, Sahay R, Agarwal S, Hasnani D. International Journal of Diabetes in Developing Countries. 2020 Sep;40(3):335-9.
A 2020 Update On Diabetes Technologies With Emphasis On Telemedicine During COVID-19.
Kesavadev J. Kerala Medical Journal. Vol 12: issue 3;Jul- Sept 2020: 112-115.
Diabetes and coronavirus disease-2019 (COVID-19).
Unnikrishnan R, Saboo B, Kesavadev J, Deshpande N, Ramachandra Aravind S. R, Joshi S, Anjana R. M, Hussain A, Mohan V. J Diabetol. Jun 2020;11:52-6.
Harnessing the Possibilities of Telemedicine for Consultations in COVID
Crisis.Kesavadev J. Int J Diab May 2020;1-6.
Our Hospital & Research Branches
Accessible, world-class comprehensive diabetes care and clinical research across 5 strategic locations.